ASM vs. SRPT

Last updated Apr 1, 2026

Compare and contrast key facts about Avino Silver & Gold Mines Ltd. (ASM) and Sarepta Therapeutics, Inc. (SRPT).

Performance

ASM vs. SRPT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avino Silver & Gold Mines Ltd. (ASM) and Sarepta Therapeutics, Inc. (SRPT). The values are adjusted to include any dividend payments, if applicable.

ASM vs. SRPT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
ASM Avino Silver & Gold Mines Ltd.	1.77%	604.88%	68.13%	-22.95%	-21.01%	-33.77%	124.14%	-4.92%	-54.48%	-2.19%
SRPT Sarepta Therapeutics, Inc.	1.12%	-82.30%	26.09%	-25.58%	43.90%	-47.18%	32.12%	18.24%	96.14%	102.84%

Fundamentals

Market Cap ASM : $1.04B SRPT : $2.28B
EPS ASM : $0.17 SRPT : -$8.11
PS Ratio ASM : 11.37 SRPT : 1.03
PB Ratio ASM : 4.45 SRPT : 2.00
Total Revenue (TTM) ASM : $88.12M SRPT : $2.20B
Gross Profit (TTM) ASM : $44.14M SRPT : -$1.05B
EBITDA (TTM) ASM : $39.90M SRPT : -$778.95M

Returns By Period

In the year-to-date period, ASM achieves a 1.77% return, which is significantly higher than SRPT's 1.12% return. Over the past 10 years, ASM has outperformed SRPT with an annualized return of 20.13%, while SRPT has yielded a comparatively lower 0.86% annualized return.

ASM

• 1D: 8.78%
• 1M: -34.30%
• YTD: 1.77%
• 6M: 20.38%
• 1Y: 243.48%
• 3Y*: 92.57%
• 5Y*: 37.41%
• 10Y*: 20.13%

SRPT

• 1D: 6.25%
• 1M: 29.83%
• YTD: 1.12%
• 6M: 12.92%
• 1Y: -65.90%
• 3Y*: -45.95%
• 5Y*: -22.17%
• 10Y*: 0.86%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ASM vs. SRPT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASM

ASM Risk / Return Rank: 93
ASM Sharpe Ratio Rank: 96
ASM Sortino Ratio Rank: 92
ASM Omega Ratio Rank: 89
ASM Calmar Ratio Rank: 92
ASM Martin Ratio Rank: 93

SRPT

SRPT Risk / Return Rank: 17
SRPT Sharpe Ratio Rank: 16
SRPT Sortino Ratio Rank: 20
SRPT Omega Ratio Rank: 18
SRPT Calmar Ratio Rank: 11
SRPT Martin Ratio Rank: 22

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASM vs. SRPT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avino Silver & Gold Mines Ltd. (ASM) and Sarepta Therapeutics, Inc. (SRPT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ASM	SRPT	Difference
Sharpe ratio Return per unit of total volatility	2.93	-0.60	+3.53
Sortino ratio Return per unit of downside risk	3.03	-0.47	+3.50
Omega ratio Gain probability vs. loss probability	1.38	0.93	+0.46
Calmar ratio Return relative to maximum drawdown	4.47	-0.85	+5.32
Martin ratio Return relative to average drawdown	13.63	-1.09	+14.72
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ASM vs. SRPT - Sharpe Ratio Comparison

The current ASM Sharpe Ratio is 2.93, which is higher than the SRPT Sharpe Ratio of -0.60. The chart below compares the historical Sharpe Ratios of ASM and SRPT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ASM	SRPT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	2.93	-0.60	+3.53
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.58	-0.32	+0.90
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	0.29	0.01	+0.28
Sharpe Ratio (All Time) Calculated using the full available price history	0.09	-0.02	+0.11

Correlation

The correlation between ASM and SRPT is 0.07, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ASM vs. SRPT - Dividend Comparison

Neither ASM nor SRPT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ASM vs. SRPT - Drawdown Comparison

The maximum ASM drawdown since its inception was -94.10%, roughly equal to the maximum SRPT drawdown of -98.17%. Use the drawdown chart below to compare losses from any high point for ASM and SRPT.

Drawdown Indicators

	ASM	SRPT	Difference
Max Drawdown Largest peak-to-trough decline	-94.10%	-98.17%	+4.07%
Max Drawdown (1Y) Largest decline over 1 year	-52.40%	-81.26%	+28.86%
Max Drawdown (5Y) Largest decline over 5 years	-70.08%	-92.72%	+22.64%
Max Drawdown (10Y) Largest decline over 10 years	-90.91%	-93.33%	+2.42%
Current Drawdown Current decline from peak	-43.77%	-87.83%	+44.06%
Average Drawdown Average peak-to-trough decline	-64.02%	-68.01%	+3.99%
Ulcer Index Depth and duration of drawdowns from previous peaks	17.20%	63.49%	-46.29%

Volatility

ASM vs. SRPT - Volatility Comparison

The current volatility for Avino Silver & Gold Mines Ltd. (ASM) is 28.16%, while Sarepta Therapeutics, Inc. (SRPT) has a volatility of 35.20%. This indicates that ASM experiences smaller price fluctuations and is considered to be less risky than SRPT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ASM	SRPT	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.16%	35.20%	-7.04%
Volatility (6M) Calculated over the trailing 6-month period	67.30%	70.73%	-3.43%
Volatility (1Y) Calculated over the trailing 1-year period	83.71%	110.30%	-26.59%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	65.03%	69.77%	-4.74%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	70.32%	75.48%	-5.16%

Financials